These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32131978)
81. Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus. Li X; Kleeman S; Coburn SB; Fumagalli C; Perner J; Jammula S; Pfeiffer RM; Orzolek L; Hao H; Taylor PR; Miremadi A; Galeano-Dalmau N; Lao-Sirieix P; Tennyson M; MacRae S; Cook MB; Fitzgerald RC Gastroenterology; 2018 Sep; 155(3):771-783.e3. PubMed ID: 29906417 [TBL] [Abstract][Full Text] [Related]
82. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p. Zhu Y; Li T; Chen G; Yan G; Zhang X; Wan Y; Li Q; Zhu B; Zhuo W Lung Cancer; 2017 Dec; 114():6-11. PubMed ID: 29173767 [TBL] [Abstract][Full Text] [Related]
83. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340 [TBL] [Abstract][Full Text] [Related]
84. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis. Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240 [TBL] [Abstract][Full Text] [Related]
85. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175 [TBL] [Abstract][Full Text] [Related]
86. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma. Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431 [TBL] [Abstract][Full Text] [Related]
87. Potential application of p53 as an intermediate biomarker in Barrett's esophagus. Jones DR; Davidson AG; Summers CL; Murray GF; Quinlan DC Ann Thorac Surg; 1994 Mar; 57(3):598-603. PubMed ID: 8147627 [TBL] [Abstract][Full Text] [Related]
88. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917 [TBL] [Abstract][Full Text] [Related]
89. Endoscopic features of buried Barrett's mucosa. Yang LS; Holt BA; Williams R; Norris R; Tsoi E; Cameron G; Desmond P; Taylor ACF Gastrointest Endosc; 2021 Jul; 94(1):14-21. PubMed ID: 33373645 [TBL] [Abstract][Full Text] [Related]
90. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182 [TBL] [Abstract][Full Text] [Related]
91. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
92. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture. Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261 [TBL] [Abstract][Full Text] [Related]
93. A combination of four serum miRNAs for screening of lung adenocarcinoma. Wang J; Zhang C; Peng X; Liu K; Zhao L; Chen X; Yu H; Lai Y Hum Cell; 2020 Jul; 33(3):830-838. PubMed ID: 32388809 [TBL] [Abstract][Full Text] [Related]
95. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer. Juzėnas S; Saltenienė V; Kupcinskas J; Link A; Kiudelis G; Jonaitis L; Jarmalaite S; Kupcinskas L; Malfertheiner P; Skieceviciene J PLoS One; 2015; 10(7):e0132327. PubMed ID: 26172537 [TBL] [Abstract][Full Text] [Related]
96. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort. Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204 [TBL] [Abstract][Full Text] [Related]
97. Origins of Metaplasia in Barrett's Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease? Zhang W; Wang DH Dig Dis Sci; 2018 Aug; 63(8):2005-2012. PubMed ID: 29675663 [TBL] [Abstract][Full Text] [Related]
98. A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study. Miyoshi J; Zhu Z; Luo A; Toden S; Zhou X; Izumi D; Kanda M; Takayama T; Parker IM; Wang M; Gao F; Zaidi AH; Baba H; Kodera Y; Cui Y; Wang X; Liu Z; Goel A Mol Cancer; 2022 Feb; 21(1):44. PubMed ID: 35148754 [TBL] [Abstract][Full Text] [Related]